Sequent Scientific バランスシートの健全性
財務の健全性 基準チェック /26
Sequent Scientificの総株主資本は₹7.4B 、総負債は₹4.5Bで、負債比率は60.9%となります。総資産と総負債はそれぞれ₹15.6Bと₹8.2Bです。 Sequent Scientificの EBIT は₹867.4Mで、利息カバレッジ比率1.6です。現金および短期投資は₹742.6Mです。
主要情報
60.9%
負債資本比率
₹4.52b
負債
| インタレスト・カバレッジ・レシオ | 1.6x |
| 現金 | ₹742.60m |
| エクイティ | ₹7.42b |
| 負債合計 | ₹8.20b |
| 総資産 | ₹15.62b |
財務の健全性に関する最新情報
We Think Sequent Scientific (NSE:SEQUENT) Is Taking Some Risk With Its Debt
Sep 27
Sequent Scientific (NSE:SEQUENT) Has A Somewhat Strained Balance Sheet
Mar 10Sequent Scientific (NSE:SEQUENT) Seems To Use Debt Rather Sparingly
Nov 22Recent updates
We Think Sequent Scientific (NSE:SEQUENT) Is Taking Some Risk With Its Debt
Sep 27What Sequent Scientific Limited's (NSE:SEQUENT) 32% Share Price Gain Is Not Telling You
Sep 05Revenues Not Telling The Story For Sequent Scientific Limited (NSE:SEQUENT)
Apr 05Sequent Scientific (NSE:SEQUENT) Has A Somewhat Strained Balance Sheet
Mar 10Is Sequent Scientific's (NSE:SEQUENT) 177% Share Price Increase Well Justified?
Jan 31How Much Did Sequent Scientific's (NSE:SEQUENT) CEO Pocket Last Year?
Jan 17Sequent Scientific Limited's (NSE:SEQUENT) Stock Is Going Strong: Have Financials A Role To Play?
Jan 05What Kind Of Investors Own Most Of Sequent Scientific Limited (NSE:SEQUENT)?
Dec 24Have Sequent Scientific Limited (NSE:SEQUENT) Insiders Been Selling Their Stock?
Dec 12
Sequent Scientific (NSE:SEQUENT) Seems To Use Debt Rather Sparingly
Nov 22Estimating The Intrinsic Value Of Sequent Scientific Limited (NSE:SEQUENT)
Nov 10The Sequent Scientific (NSE:SEQUENT) Share Price Is Up 102% And Shareholders Are Boasting About It
Oct 20How Does Sequent Scientific's (NSE:SEQUENT) CEO Pay Compare With Company Performance?
Oct 05財務状況分析
短期負債: SEQUENTの 短期資産 ( ₹8.3B ) が 短期負債 ( ₹4.9B ) を超えています。
長期負債: SEQUENTの短期資産 ( ₹8.3B ) が 長期負債 ( ₹3.3B ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: SEQUENTの 純負債対資本比率 ( 50.9% ) は 高い と見なされます。
負債の削減: SEQUENTの負債対資本比率は、過去 5 年間で43.1%から60.9%に増加しました。
債務返済能力: SEQUENTの負債は 営業キャッシュフロー によって 十分にカバーされていません ( 4.6% )。
インタレストカバレッジ: SEQUENTの負債に対する 利息支払い は EBIT ( 1.6 x coverage) によって 十分にカバーされていません。